• Wells Fargo & Company Lowers Intellia Therapeutics (NASDAQ:NTLA) Price Target to $50.00

    Source: Buzz FX / 01 Mar 2025 13:21:13   America/New_York


    Wells Fargo & Company Lowers Intellia Therapeutics (NASDAQ:NTLA) Price Target to $50.00 Written by MarketBeat March 1, 2025 Share Link copied to clipboard. Intellia Therapeutics ( NASDAQ:NTLA - Get Free Report ) had its price objective drop
    Read more...
Share on,